<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-vetsci-02-00456">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Balzarini</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Vahlenkamp</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Egberink</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hartmann</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Witvrouw</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pannecouque</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Casara</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Nave</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>de Clercq</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and mdl 74,968] in cell cultures and murine sarcoma virus-infected newborn nmri mice</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>1997</year>
  <volume>41</volume>
  <fpage>611</fpage>
  <lpage>616</lpage>
  <?supplied-pmid 9056002?>
  <pub-id pub-id-type="pmid">9056002</pub-id>
 </element-citation>
</ref>
